deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT01257776

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

Using Mesenchymal Stem Cells From Adipose Tissue (CeTMAd) as Cell Regeneration Therapy in Chronic Ischemic Syndrome of Lower Limbs in Diabetic Patients

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

Conditions Critical Limb Ischemia (CLI) Diabetes
Interventions Autologous adipose derived mesenchymal stem cells
Updated 6 times since 2017 Last updated: Aug 4, 2015 Started: Dec 31, 2010 Primary completion: Feb 28, 2013 Completion: Jul 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01257776, this PHASE1/PHASE2 trial focuses on Critical Limb Ischemia (CLI) and Diabetes and remains completed. Sponsored by Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jun 2018 — Feb 2020 [monthly]

    Completed PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
  • Iniciativa Andaluza en Terapias Avanzadas
Data source: Andalusian Network for Design and Translation of Advanced Therapies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations